Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pacific Edge Limited ( (PFGTF) ) has issued an update.
Pacific Edge Limited has announced the application for quotation of 190,319 ordinary fully paid foreign exempt securities on the ASX, with an issue date of October 7, 2025. This move is part of the company’s strategy to enhance its market presence and liquidity, potentially impacting its operational capabilities and offering new opportunities for stakeholders.
More about Pacific Edge Limited
Pacific Edge Limited operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests for the early detection and management of cancer. The company is known for its innovative cancer diagnostic solutions, aiming to provide non-invasive, accurate, and cost-effective testing options.
For an in-depth examination of PFGTF stock, go to TipRanks’ Overview page.